Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature

BACKGROUND: Aprepitant is an FDA-approved medication for chemotherapy-induced nausea and vomiting. It blocks substance P binding to neurokinin-1; substance P has been implicated in itch pathways both as a local and global mediator. CASE PRESENTATIONS: We report a series of four patients, diagnosed w...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Cancer
Main Authors: Song, Johanna S., Tawa, Marianne, Chau, Nicole G., Kupper, Thomas S., LeBoeuf, Nicole R.
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2017
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356405/
https://ncbi.nlm.nih.gov/pubmed/28302100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3194-8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker